Tactile Systems Technology, Inc. 是一家醫療技術公司,致力於在美國開發及供應治療慢性疾病的醫療器械。公司總部位於明尼蘇達州明尼阿波利斯。
財務指標
營業收入
2026-06-30
$85.69M
2026-03-31
$75.26M
2025-12-31
$103.59M
2025-09-30
$85.75M
營業支出
2026-06-30
$52.03M
2026-03-31
$59.14M
2025-12-31
$59.78M
2025-09-30
$54.03M
淨利潤
2026-06-30
$7.78M
2026-03-31
-$1.76M
2025-12-31
$10.63M
2025-09-30
$8.2M
淨利潤率
2026-06-30
9.08%
2026-03-31
-2.34%
2025-12-31
10.26%
2025-09-30
9.57%
每股收益
2026-06-30
$0.34
2026-03-31
$0.00
2025-12-31
$0.46
2025-09-30
$0.36
息稅折舊攤銷前利潤
2026-06-30
$9.19M
2026-03-31
$771K
2025-12-31
$21.08M
2025-09-30
$13.07M
有效稅率
2026-06-30
-5.65%
2026-03-31
-96.76%
2025-12-31
45.32%
2025-09-30
28.22%
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$85.69M
$75.26M
$103.59M
$85.75M
營業支出
$52.03M
$59.14M
$59.78M
$54.03M
淨利潤
$7.78M
-$1.76M
$10.63M
$8.2M
淨利潤率
9.08%
-2.34%
10.26%
9.57%
每股收益
$0.34
$0.00
$0.46
$0.36
息稅折舊攤銷前利潤
$9.19M
$771K
$21.08M
$13.07M
有效稅率
-5.65%
-96.76%
45.32%
28.22%
常見問題
TCMD represents shares of Tactile Systems Technology, Inc., a U.S.-based medical device company. The stock trades on the Nasdaq Global Market under the ticker TCMD. It is a common equity security, meaning shareholders own a fractional interest in the company. TCMD does not represent an ETF, mutual fund, or fixed-income product. For the latest company profile and security details, refer to the TCMD quote page.
TCMD operates in the healthcare sector, specifically within the medical devices industry. The company develops and markets devices used for at-home therapy of chronic vascular and lymphatic conditions, such as lymphedema and venous insufficiency. This places TCMD in a niche of the broader medtech space, which includes companies focused on non-invasive treatment technologies. Because industry classification can vary by data provider, the TCMD page may list a more specific sub-industry.
Recent performance for TCMD depends on current market activity. The stock price changes daily during regular Nasdaq trading hours based on supply and demand. To see the latest move, including the most recent close, daily change, and percentage change, check the live price and performance data displayed on the TCMD stock page. Historical performance information may also be available in the chart section.
Evaluating TCMD's valuation typically involves comparing its market price to financial fundamentals such as revenue, earnings, and cash flow. Common metrics include price-to-sales, price-to-earnings, and enterprise value multiples. Because TCMD is a medical device company, investors often look at growth trends and profitability alongside these ratios. Any current valuation data should be taken from the TCMD page, since these figures change with the stock price and reported financials.
To buy TCMD shares, you generally need a brokerage account that offers access to U.S. stock exchanges. Once funded, you can place a buy order for TCMD using the ticker symbol during regular Nasdaq market hours, or check whether your broker supports extended-hours trading. Orders can be market or limit orders, depending on your preference. Fractional shares may be available through some brokers, but availability varies. Always confirm trading details with your brokerage.
TCMD faces risks common to small- and mid-cap medical device companies, including competition, regulatory changes, reimbursement pressures, and product adoption challenges. Its stock price can also be sensitive to quarterly results, guidance changes, and broader healthcare sector sentiment. Because TCMD operates in a specialized market, slower-than-expected growth or clinical setbacks could affect performance. These risks should be weighed alongside the company's financial disclosures and industry conditions.